Preparing for the next Zika (original) (raw)

• Commentary
• Published: 07 April 2016

Nature Biotechnology volume 34, pages 384–386 (2016)Cite this article

• 4259 Accesses
• 14 Citations
• 94 Altmetric
• Metrics details

Subjects

Lessons from the US Biodefense program should inform international efforts to build a medical countermeasure enterprise for emerging infectious diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

• Promoting versatile vaccine development for emerging pandemics

  • Joshua T. Monrad
  • , Jonas B. Sandbrink
  • & Neil G. Cherian
    npj Vaccines Open Access 11 February 2021

• An equity-oriented rethink of global rankings with complex networks mapping development

  • Loredana Bellantuono
  • , Alfonso Monaco
  • … Roberto Bellotti
    Scientific Reports Open Access 22 October 2020

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

• Purchase on SpringerLink
• Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

• Log in
• Learn about institutional subscriptions
• Read our FAQs
• Contact customer support

References

1. Lee, J.W. & McKibbin, W.J. in Knobler, S. et al. (eds.) Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary (Washington, DC: National Academies Press; 2004).
   Google Scholar
2. Thomas, M.R. et al. The Economic Impact of Ebola on Sub-Saharan Africa: Updated Estimates for 2015. http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2015/01/19/000112742_20150119170232/Rendered/PDF/937210REVISED000Jan02002015000FINAL.pdf (World Bank Group, 20 January 2015).
   Google Scholar
3. Wright, S. & Hanna, L. A Wake up Call: Lessons from Ebola for the World's Health Systems, Save the Children http://www.savethechildren.org.uk/sites/default/files/images/A-Wake-Up-Call.pdf (Save The Children, Washington, DC, 2015).
   Google Scholar
4. Pronker, E.S., Weenen, T.C., Commandeur, H.R., Osterhaus, A.D. & Claassen, H.J. Vaccine 29, 5846–5849 (2011).
   Article CAS Google Scholar
5. Plotkin, S., Mahmoud, A. & Farrar, J. N. Engl. J. Med. 373, 297–300 (2015).
   Article CAS Google Scholar
6. Gates, B. N. Engl. J. Med. 372, 1381–1384 (2015).
   Article CAS Google Scholar
7. Commission on a Global Health Risk Framework for the Future. The Neglected Dimension of Global Security. http://nam.edu/initiatives/global-health-risk-framework/ (National Academy of Medicine; Washington, DC, 2015).
8. World Health Organization. Outcome document: Financing of R&D Preparedness and Response to Epidemic Emergencies. http://www.who.int/medicines/ebola-treatment/Outcome.pdf?ua=1 (WHO, Geneva, Switzerland, October 2015).
9. Borio, L., Cox, E. & Lurie, N. N. Engl. J. Med. 373, 993–995 (2015).
   Article Google Scholar
10. Hoyt, K. Long Shot; Vaccines for National Defense (Harvard University Press, Cambridge, MA, USA, 2012).
    Book Google Scholar
11. Lang, T. Nature 524, 29–31 (2015).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

1. Kendall Hoyt is at the Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.,
   Kendall Hoyt
2. Richard Hatchett is acting director of the Biomedical Advanced Research and Development Authority (HHS/ASPR/BARDA), Washington, DC, USA.,
   Richard Hatchett

Authors

1. Kendall Hoyt
2. Richard Hatchett

Corresponding author

Correspondence toKendall Hoyt.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Hoyt, K., Hatchett, R. Preparing for the next Zika.Nat Biotechnol 34, 384–386 (2016). https://doi.org/10.1038/nbt.3532

Download citation

• Published: 07 April 2016
• Issue date: April 2016
• DOI: https://doi.org/10.1038/nbt.3532

This article is cited by